Quoin Pharmaceuticals sets 2025 AGM for August 21; shareholder proposal deadline June 30

Quoin Pharmaceuticals, Ltd.

2025 Annual General Meeting scheduled for August 21, 2025.
Shareholder proposals under Rule 14a-8 must be received by June 30, 2025.
Notice for proxy solicitations for director nominees other than company's must be given by June 30, 2025.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.